Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality

AIMS/HYPOTHESIS: Diabetes is associated with an increased risk of cancer. Prostasin is an epithelial sodium channel stimulator that has been associated with suppression of tumours, glucose metabolism and hyperglycaemia-associated tumour pathology. However, the association between prostasin, diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Xue, Xu, Biao, Muhammad, Iram Faqir, Nilsson, Peter M., Nilsson, Jan, Engström, Gunnar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477896/
https://www.ncbi.nlm.nih.gov/pubmed/35922613
http://dx.doi.org/10.1007/s00125-022-05771-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477896/
https://www.ncbi.nlm.nih.gov/pubmed/35922613
http://dx.doi.org/10.1007/s00125-022-05771-w

Ejemplares similares